These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 16255750)

  • 21. Trends in treated ventricular fibrillation out-of-hospital cardiac arrest: a 17-year population-based study.
    Bunch TJ; White RD; Friedman PA; Kottke TE; Wu LA; Packer DL
    Heart Rhythm; 2004 Sep; 1(3):255-9. PubMed ID: 15851165
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Implantable cardioverter-defibrillator therapy before death: high risk for painful shocks at end of life.
    Kinch Westerdahl A; Sjöblom J; Mattiasson AC; Rosenqvist M; Frykman V
    Circulation; 2014 Jan; 129(4):422-9. PubMed ID: 24243857
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of spironolactone on ventricular tachyarrhythmias in patients with implantable cardioverter-defibrillators.
    Zarraga IG; Dougherty CM; MacMurdy KS; Raitt MH
    Circ Arrhythm Electrophysiol; 2012 Aug; 5(4):739-47. PubMed ID: 22773022
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Electrophysiologist-implanted transvenous cardioverter defibrillators using local versus general anesthesia.
    Manolis AS; Maounis T; Vassilikos V; Chiladakis J; Cokkinos DV
    Pacing Clin Electrophysiol; 2000 Jan; 23(1):96-105. PubMed ID: 10666758
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The dilemma of ICD implant testing.
    Swerdlow CD; Russo AM; Degroot PJ
    Pacing Clin Electrophysiol; 2007 May; 30(5):675-700. PubMed ID: 17461879
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical relevance of slow ventricular tachycardia in heart failure patients with primary prophylactic implantable cardioverter defibrillator indication.
    Lüsebrink U; Duncker D; Hess M; Heinrichs I; Gardiwal A; Oswald H; König T; Klein G
    Europace; 2013 Jun; 15(6):820-6. PubMed ID: 23325044
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Implantable cardioverter-defibrillators in patients with hypertrophic cardiomyopathy -- dilemmas and difficulties.
    Przybylski A; Małecka L; Pytkowski M; Chojnowska L; Lewandowski M; Sterliński M; Maciag A; Ruzyłło W; Szwed H
    Kardiol Pol; 2005 Oct; 63(4):391-7; discussion 398. PubMed ID: 16273479
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ventricular arrhythmias in patients with implanted cardioverter defibrillators.
    John RM; Stevenson WG
    Trends Cardiovasc Med; 2012 Oct; 22(7):169-73. PubMed ID: 22902094
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Electromagnetic interference between automatic defibrillators and digital and analog cellular telephones].
    Jiménez A; Hernández Madrid A; Pascual J; González Rebollo JM; Fernández E; Sánchez A; Ortega J; Lozano F; Muñoz R; Moro C
    Rev Esp Cardiol; 1998 May; 51(5):375-82. PubMed ID: 9644961
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Antitachyarrhythmic interventions of implantable cardioverter-defibrillator in primary and secondary sudden cardiac death prevention patients].
    Piekarz J; Rydlewska A; Majewski J; Lelakowski J
    Pol Merkur Lekarski; 2012 Jun; 32(192):368-73. PubMed ID: 22891561
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined third-generation implantable cardioverter defibrillator with permanent unipolar pacemakers: preliminary observations.
    Haffajee C; Casavant D; Desai P; Moon R; Voukydis P; Pacetti P
    Pacing Clin Electrophysiol; 1996 Feb; 19(2):136-42. PubMed ID: 8834682
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differences in outcomes between patients treated with single- versus dual-chamber implantable cardioverter defibrillators: a substudy of the Multicenter Automatic Defibrillator Implantation Trial II.
    Berenbom LD; Weiford BC; Vacek JL; Emert MP; Hall WJ; Andrews ML; McNitt S; Zareba W; Moss AJ
    Ann Noninvasive Electrocardiol; 2005 Oct; 10(4):429-35. PubMed ID: 16255753
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
    Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S
    Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ventricular tachycardia or ventricular fibrillation occurs less often in patients with left bundle branch block and combined resynchronization and defibrillators than in patients with narrow QRS and conventional defibrillators.
    Blaschke F; Knaus T; Celebi O; Krebs A; Nitardy A; Habedank D; Dietz R; Stockburger M
    Europace; 2012 Feb; 14(2):224-9. PubMed ID: 21946820
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Implantable cardioverter-defibrillators in lamin A/C mutation carriers with cardiac conduction disorders.
    Anselme F; Moubarak G; Savouré A; Godin B; Borz B; Drouin-Garraud V; Gay A
    Heart Rhythm; 2013 Oct; 10(10):1492-8. PubMed ID: 23811080
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of celivarone, with amiodarone as calibrator, in patients with an implantable cardioverter-defibrillator for prevention of implantable cardioverter-defibrillator interventions or death: the ALPHEE study.
    Kowey PR; Crijns HJ; Aliot EM; Capucci A; Kulakowski P; Radzik D; Roy D; Connolly SJ; Hohnloser SH;
    Circulation; 2011 Dec; 124(24):2649-60. PubMed ID: 22082672
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Near-Fatal ICD Lead Dysfunction with Implications for ICD Testing.
    Wutzler A; Attanasio P; Haverkamp W; Blaschke F
    Pacing Clin Electrophysiol; 2016 Jan; 39(1):105-6. PubMed ID: 26519249
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Undersensing of ventricular fibrillation due to interference between a pacemaker and defibrillator in the same patient.
    Van Casteren L; Huybrechts W; Willems R
    Europace; 2009 Oct; 11(10):1390-1. PubMed ID: 19654130
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Electrical Storms in Patients With Implantable Cardioverter-Defibrillators for Primary Prevention.
    Escande W; Marijon E; Defaye P; Piot O; Leclercq C; Sadoul N; Deharo JC; Empana JP; Boveda S; Klug D
    J Am Coll Cardiol; 2016 Sep; 68(11):1248-1250. PubMed ID: 27609689
    [No Abstract]   [Full Text] [Related]  

  • 40. Impact of the implantable cardioverter-defibrillator on rehospitalizations.
    Valenti R; Schlåpfer J; Fromer M; Fischer A; Kappenberger L
    Eur Heart J; 1996 Oct; 17(10):1565-71. PubMed ID: 8909915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.